title: Substance misuse prevention: addressing anhedonia.
abstract: Anhedonia refers to the inability of experiencing pleasure in positive life events. It has been conceptualized as a stable yet malleable characteristic and is associated with hypoactivity in the mesolimbic and mesocortical dopaminergic systems. Very recently, it has been posited as an etiologic factor associated with drug addiction onset, escalation, and relapse. Prevention programming could be developed to counteract the harmful impact of anhedonia, so as to minimize its impact on drug misuse. Remedial efforts are those that either (1) permit the individual to tolerate low levels of pleasure without resorting to drug misuse or other maladaptive behaviors that may unhealthily besot pleasure (for example, through normalization, structuring time, or meditation) or (2) counteract anhedonia by enhancing ones capability to experience pleasure (for example, behavioral activation, positive psychology, pharmacotherapy, or pursuit of positive addictions). School-based activities could be developed that can be completed by individuals, small workgroups, or the whole classroom. The concept of anhedonia is described in this chapter, and possible prevention strategies that might be utilized in schools as well as other contexts are discussed.
authors.affiliation: Preventive Medicine and Psychology, University of Southern California.
authors.forename: Steve
authors.initials: S
authors.lastname: Sussman
authors.forename: Adam
authors.initials: A
authors.lastname: Leventhal
mesh_terms: D000293:Adolescent; D059445:Anhedonia; D006801:Humans; D016730:Program Development / Q000592:standards*; D012574:Schools / Q000458:organization & administration*; D019966:Substance-Related Disorders / Q000517:prevention & control*
references.citation: Can Psychiatr Assoc J. 1978 Nov;23(7):487-92
references.pmid: 709497
references.citation: J Am Acad Child Adolesc Psychiatry. 1995 Dec;34(12):1608-17
references.pmid: 8543532
references.citation: J Psychopharmacol. 2007 Jul;21(5):461-71
references.pmid: 17050654
references.citation: Subst Use Misuse. 2013 Sep;48(12):1203-17
references.pmid: 24041182
references.citation: Nicotine Tob Res. 2012 May;14(5):559-68
references.pmid: 22180578
references.citation: Annu Rev Psychol. 2011;62:189-214
references.pmid: 19575606
references.citation: Psychol Med. 1993 Nov;23(4):957-66
references.pmid: 8134519
references.citation: Clin Psychol Rev. 2003 Oct;23(5):699-717
references.pmid: 12971906
references.citation: Eval Health Prof. 2011 Mar;34(1):3-56
references.pmid: 20876085
references.citation: Nicotine Tob Res. 2012 Oct;14(10):1187-96
references.pmid: 22387990
references.citation: CNS Spectr. 2008 Jul;13(7):561-5
references.pmid: 18622360
references.citation: J Consult Clin Psychol. 2010 Feb;78(1):55-61
references.pmid: 20099950
references.citation: Clin Psychol Rev. 1998 Nov;18(7):765-94
references.pmid: 9827321
references.citation: Psychopharmacology (Berl). 1992;109(4):433-8
references.pmid: 1365858
references.citation: Biol Psychiatry. 2006 Nov 15;60(10):1147-54
references.pmid: 16806107
references.citation: Sucht. 2012 Oct 1;58(5):317-325
references.pmid: 23885135
references.citation: J Abnorm Psychol. 1995 May;104(2):390-4
references.pmid: 7790642
references.citation: Cochrane Database Syst Rev. 2012 Jul 11;(7):CD004366
references.pmid: 22786489
references.citation: Brain Cogn. 2010 Feb;72(1):114-23
references.pmid: 19762139
references.citation: Addict Behav. 2003 Aug;28(6):1159-66
references.pmid: 12834658
references.citation: J Abnorm Psychol. 1993 Aug;102(3):474-81
references.pmid: 8408960
references.citation: Exp Clin Psychopharmacol. 2010 Dec;18(6):562-9
references.pmid: 21186931
references.citation: J Abnorm Psychol. 2001 Feb;110(1):188-93
references.pmid: 11261394
references.citation: Front Psychiatry. 2011 Mar 17;2:10
references.pmid: 21556280
references.citation: J Posit Psychol. 2014 Jan 1;9(1):19-29
references.pmid: 24683417
references.citation: J Abnorm Child Psychol. 2009 May;37(4):507-20
references.pmid: 19184402
references.citation: Br J Psychiatry. 1995 Jul;167(1):99-103
references.pmid: 7551619
references.citation: Prog Neurobiol. 2010 Dec;92(4):572-92
references.pmid: 20713127
references.citation: Prog Neuropsychopharmacol Biol Psychiatry. 2006 Mar;30(2):297-300
references.pmid: 16303225
references.citation: Eur Child Adolesc Psychiatry. 2008 Aug;17(5):274-82
references.pmid: 18301941